Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Anti-government activist fails to discharge $52M judgment owed to St. Luke’s

Ammon Bundy attempted to use bankruptcy court to wipe his slate clean. However, a federal court ruled that he still owes St. Luke’s the full amount of the 2023 defamation judgment, plus interest.

radiology structured reporting data mining

Could ChatGPT be up to the task of monitoring AI drift?

Artificial intelligence tools in radiology require constant monitoring to ensure model performance remains consistent.

abortion law ban pregnancy dobbs

Abortion-access nonprofit sued for wrongful death after alleged dosing incident

A woman in Texas alleges a U.S. Marine slipped abortion pills into her hot chocolate, resulting in the death of her fetus. She is suing the man, along with Aid Access—a nonprofit that provides nationwide access to abortion pills via telehealth.

Heartflow president and CEO John Farquhar celebrate the company's IPO by ringing Nasdaq's the ceremonial opening bell.

Heartflow raises $364M with IPO, rings Nasdaq opening bell

Heartflow has officially gone public after selling more than 19 million shares of common stock during an upsized IPO. The California medtech company, known for its AI-powered CCTA evaluations, is now being traded on Nasdaq under the symbol HTFL.

warning safety alert recall healthcare issue

FDA recalls breathing system filters after multiple injuries

Multiple lots of Draeger SafeStar and TwinStar filters—which are typically used during mechanical ventilation—are being removed from where they’re used and sold due to erroneous carbon dioxide readings.

Cardiac amyloidosis ATTR-CM drug promotion at the 2024 American Heart Association meeting.

High cost of cardiac amyloidosis drugs may limit access for low-income patients

"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.

Thumbnail

Healthcare AI today: Bad health advice, ChatGPT 5 ‘highly reliable’ for healthcare, Colorado punts, more

Accepting medical guidance from a large language model landed a 60-year-old man in the emergency room. 

Imaging groups urge Trump administration to exempt radiopharmaceuticals, medical isotopes from tariffs

Six physician professional associations recently made their case in a letter to Howard Lutnick, secretary of the U.S. Department of Commerce.